Medacta Group (Switzerland) Price Patterns
| MOVE Stock | 148.60 1.40 0.95% |
Momentum 53
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 0.584 | EPS Estimate Current Year 4.5062 | EPS Estimate Next Year 5.3109 | Wall Street Target Price 177.8957 | Quarterly Revenue Growth 0.192 |
Using Medacta Group hype-based prediction, you can estimate the value of Medacta Group SA from the perspective of Medacta Group response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Medacta Group to buy its stock at a price that has no basis in reality. In that case, they are not buying Medacta because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Medacta Group after-hype prediction price | CHF 148.62 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Medacta |
Medacta Group After-Hype Price Density Analysis
As far as predicting the price of Medacta Group at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Medacta Group or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Medacta Group, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Medacta Group Estimiated After-Hype Price Volatility
In the context of predicting Medacta Group's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Medacta Group's historical news coverage. Medacta Group's after-hype downside and upside margins for the prediction period are 146.97 and 150.27, respectively. We have considered Medacta Group's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Medacta Group is very steady at this time. Analysis and calculation of next after-hype price of Medacta Group SA is based on 3 months time horizon.
Medacta Group Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Medacta Group is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medacta Group backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Medacta Group, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.01 | 1.65 | 0.02 | 0.01 | 4 Events / Month | 2 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
148.60 | 148.62 | 0.01 |
|
Medacta Group Hype Timeline
Medacta Group SA is now traded for 148.60on SIX Swiss Exchange of Switzerland. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of -0.01. Medacta is anticipated to increase in value after the next headline, with the price projected to jump to 148.62 or above. The average volatility of media hype impact on the company the price is about 103.13%. The price increase on the next news is anticipated to be 0.01%, whereas the daily expected return is now at 0.01%. The volatility of related hype on Medacta Group is about 180.33%, with the expected price after the next announcement by competition of 148.59. The company reported the revenue of 590.58 M. Net Income was 72.89 M with profit before overhead, payroll, taxes, and interest of 436.82 M. Assuming the 90 days trading horizon the next anticipated press release will be in about 4 days. Check out Medacta Group Basic Forecasting Models to cross-verify your projections.Medacta Group Related Hype Analysis
Having access to credible news sources related to Medacta Group's direct competition is more important than ever and may enhance your ability to predict Medacta Group's future price movements. Getting to know how Medacta Group's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Medacta Group may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SFZN | Siegfried Holding | (0.50) | 5 per month | 1.37 | 0.11 | 3.13 | (2.39) | 16.64 | |
| TECN | Tecan Group AG | (1.70) | 7 per month | 0.00 | (0.04) | 4.05 | (3.61) | 12.91 | |
| BION | BB Biotech AG | 0.25 | 1 per month | 1.56 | 0.07 | 2.73 | (2.08) | 9.03 | |
| GALE | Galenica Sante AG | 0.05 | 1 per month | 0.00 | 0.23 | 1.56 | (0.98) | 3.14 | |
| YPSN | Ypsomed Holding AG | (3.00) | 3 per month | 0.00 | (0.05) | 3.35 | (3.13) | 8.61 | |
| MED | Medartis Holding AG | (0.60) | 4 per month | 1.81 | 0.1 | 3.98 | (3.71) | 9.13 | |
| SKAN | SKAN Group AG | (4.45) | 4 per month | 1.98 | 0.02 | 3.66 | (3.51) | 9.24 | |
| COPN | COSMO Pharmaceuticals SA | 0.50 | 4 per month | 1.66 | 0.23 | 6.48 | (2.87) | 26.07 | |
| CLTN | Coltene Holding AG | 0.10 | 3 per month | 1.78 | 0.15 | 3.78 | (2.64) | 11.91 | |
| AEVS | Aevis Victoria SA | 0.20 | 3 per month | 2.06 | 0 | 2.29 | (2.24) | 13.83 |
Medacta Group Additional Predictive Modules
Most predictive techniques to examine Medacta price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Medacta using various technical indicators. When you analyze Medacta charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Medacta Group Predictive Indicators
The successful prediction of Medacta Group stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Medacta Group SA, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Medacta Group based on analysis of Medacta Group hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Medacta Group's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Medacta Group's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.004097 | 0.004937 | 0.005678 | 0.005394 | Price To Sales Ratio | 5.28 | 3.84 | 4.42 | 6.38 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medacta Stock Analysis
When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.